WHO ICTRP trial
A study on the application of liquid chromatography-mass spectrometry combined…
ChiCTR2400093758 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400093758 |
|---|---|
| Public title | A study on the application of liquid chromatography-mass spectrometry combined with artificial intelligence in the analysis of plasma coenzyme Q10 content and cardiovascular disease risk assessment |
| Scientific title | A study on the application of liquid chromatography-mass spectrometry combined with artificial intelligence in the analysis of plasma coenzyme Q10 content and cardiovascular disease risk assessment |
| Primary sponsor | Sichuan Taikang Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | CVD(cardiovascular disease) |
| Interventions | Low risk CVD group:N/A;Middle risk CVD group:N/A;High risk CVD group:N/A |
| Registration date | Dec 11, 2024 |
| Target size | Low risk CVD group:200;Middle risk CVD group:200;High risk CVD group:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: